Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. Its products include Telomere Science and Teloview. The company was founded by Sabine Mai on May 25, 2011 and is headquartered in Toronto, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company